Rising demand for peptide-based therapeutics prompts the launch of this new peptide research center, which will offer services across peptide synthesis, discovery, and advanced modalities.

Monitoring and course correction. Keep the process under observation and control. Calibration. | Image credit: ©Andrii Yalanskyi – Stock.Adobe.com

Outsourcing Analytics for Process Monitoring and Optimization

By Cynthia A. Challener

February 4th 2025

Developers save money and time while accessing expertise.

Abzena Launches GMP Cell-Based Potency Testing in US and UK Sites, Boosting Analytical Capabilities

By Feliza Mirasol

November 22nd 2024

The company will now include GMP cell-based potency assays at its Cambridge, UK, and San Diego, Calif., sites expanding its early and late phase analytical capabilities.

BioPharmaSpec Launches Three New R&D Facilities in Europe

By Feliza Mirasol

November 20th 2024

The new European facilities located in German, Italy, and Lithuania will specialize in drug discovery and R&D services.

Thermo Fisher Introduces New CDMO and CRO Services at CPHI Milan 2024

By Patrick Lavery

October 10th 2024

Thermo Fisher Scientific's launch of its Accelerator Drug Development follows expansions of sites in Cincinnati, Ohio, and Bend, Ore., earlier in 2024 to enable R&D, manufacturing, and testing.

<1 2 3 4 5

About Us

Advertise

Editorial Information

Do Not Sell My Personal Information

Terms and Conditions

Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777